A New Weapon in the Battle Against Lung Cancer
Lung cancer is a major health issue around the world. Among the different types, non-small cell lung cancer (NSCLC) is particularly tough to treat. However, a new drug named osimertinib is making waves. It's not your typical cancer treatment. Instead, it's designed to target specific EGFR gene mutations found in some cases of NSCLC. EGFR mutations can cause cancer c...